Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Delcath Systems Inc (DCTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,739
  • Shares Outstanding, K 930
  • Annual Sales, $ 2,720 K
  • Annual Income, $ -45,120 K
  • 36-Month Beta -0.67
  • Price/Sales 0.62
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12,234.78
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7600 +1.70%
on 08/08/18
2.6000 -31.15%
on 07/16/18
-0.9500 (-34.67%)
since 07/13/18
3-Month
1.7600 +1.70%
on 08/08/18
4.4000 -59.32%
on 05/16/18
-1.3600 (-43.17%)
since 05/14/18
52-Week
1.2200 +46.72%
on 05/03/18
42,000.0000 -100.00%
on 08/18/17
-17,498.2100 (-99.99%)
since 08/14/17

Most Recent Stories

More News
Summary of Calendar for Upcoming Proposed Delcath Rights Offering

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, reminds investors that the ownership date cutoff for the Company's...

DCTH : 1.7900 (-4.28%)
Delcath Systems Announces Rights Offering and Backstop Commitment Ownership Date of August 1, 2018

Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that it has filed a registration statement on Form...

DCTH : 1.7900 (-4.28%)
Delcath Announces 100th Commercial CHEMOSAT Treatment Completed at Leiden University Medical Center, The Netherlands

Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that physicians at Leiden University Medical Center...

DCTH : 1.7900 (-4.28%)
Delcath Systems to Present at the 8th Annual LD Micro Invitational

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that it will be presenting at the 8 Annual LD Micro...

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)
Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, is proud to sponsor A Cure In Sight and its first annual Looking...

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)
Delcath's CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the German Guidelines Program in Oncology (GGPO)...

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)
Delcath's PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's PHP Therapy was featured in a Video...

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)
Delcath Announces First Quarter 2018 Financial Results

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the quarter ended March 31, 2018....

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)
Delcath Systems, Technology Overview, Product Developments and FYE 2017 Review

NEW YORK, NY / ACCESSWIRE / May 8, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report...

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)
Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma

Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company has initiated its pivotal trial of Melphalan...

DCTH : 1.7900 (-4.28%)
DCTHD : 3.0000 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade DCTH with:

Key Turning Points

2nd Resistance Point 1.9633
1st Resistance Point 1.8767
Last Price 1.7900
1st Support Level 1.7467
2nd Support Level 1.7033

See More

52-Week High 42,000.0000
Fibonacci 61.8% 25,956.4640
Fibonacci 50% 21,000.6090
Fibonacci 38.2% 16,044.7530
Last Price 1.7900
52-Week Low 1.2200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar